U.S. scientists say a drug could extend the life span of liver cancer patients

liver cancer is a hard-to-cure cancer, with 600,000 people diagnosed with it every year, but the medical community has long lacked drugs to treat it effectivelyRecently, U.Sscientists announced that they have developed a drug that can extend the life span of liver cancer patients, meaning that for the first time in the search for drugs to treat liver cancer, a breakthrough has been madeScientists
say they have done very good results in clinical trials of 602 patients around the world, meaning that future treatments for liver cancer may change in the medical community.
The trial, which began in March 2005, began with patients taking two tablets a day called Sorafenib, and so far, patients have lived an average of 10.7 months longer, with some still alive"This is an unprecedented breakthrough in the treatment of liver cancer, and previous experiments have never achieved similar results," said Joseph Lovett of the Monte Sinai School of Medicine in New York, who led the studyWe have drugs that can effectively extend patients' lives"
reported that "Sorafenib" uses a "two-pronged" approach to fight cancer cellsOn the one hand, it can contain malignant cancer cells, but also can cut off the blood supply to malignanttumorIn addition, "sorafenib" can function intumors in the liver
and tumor
s that spread to other parts of the body However, it can also cause side effects of diarrhea and hand and foot pain In the study, the patient's tumor did not shrink or disappear, but mostly stopped expanding "Sorafenib doesn't kill cancer cells, but it can be very effective in preventing the disease from getting worse," Lovett said "
", "fifth largest cancer" liver cancer is currently the world's fifth most common cancer, but also one of the highest mortality cancer Patients with cirrhosis and hepatitis have the highest risk of liver cancer The U.S has 19,000 people diagnosed with liver cancer each year, a number that is even higher in Asia, especially where hepatitis vaccines are lacking Conventional chemotherapy has no obvious effect on the treatment of liver cancer Moreover, many liver cancer patients are already terminal at the time of diagnosis, and surgery is too late Many people with liver cancer die within a year of diagnosis (rereproduced from Guangzhou Daily)